A phase II trial to investigate fruquintinib in combination with paclitaxel in patients with gastric cancer

Trial Profile

A phase II trial to investigate fruquintinib in combination with paclitaxel in patients with gastric cancer

Planning
Phase of Trial: Phase II

Latest Information Update: 27 Oct 2015

At a glance

  • Drugs Fruquintinib (Primary) ; Paclitaxel
  • Indications Gastric cancer
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 27 Oct 2015 New trial record
    • 23 Oct 2015 The company expects to initiate this trial in early 2016, according to a Chi-Med media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top